Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19 Patients and Control Group and Relationship with Disease Prognosis
Título
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19 Patients and Control Group and Relationship with Disease Prognosis
Autor
Mohammad Eslamijouybari, Keyvan Heydari, Iradj Maleki, Mahmood Moosazadeh, Akbar Hedayatizadeh-Omran, Lale Vahedi, Roya Ghasemian, Ali Sharifpour, Reza Alizadeh-Navaei
Descripción
Background: The present study aimed to compare the complete blood count (CBC) indices between COVID-19 patients and the control group, and assess the relationship of these indices with COVID-19 prognosis given the role of complete blood counts in the COVID-19 prognosis. Methods: COVID-19 patients (confirmed by PCR or CT-Scan) who visited Imam Hospital in Sari were selected in this case-control study. The control group was selected from Tabari cohort population who were matched with the case group in terms of gender and age. CBC, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and outcome of the disease (in the case group) were assessed in this study. Results: The number of participants in the case and control groups was 527. Of these, 464 (44%) were females. Platelet count, lymphocyte count, and hemoglobin concentration were also higher in the control group (p = 0.000). NLR and PLR were significantly higher in COVID-19 patients compared to the control group (P = 0.000). NLR had a significant relationship with severity of the disease. NLR was two times higher in the patients who died of COVID-19 than those who recovered (P = 0.000). ROC curve analysis for diagnostic values of NLR and PLR showed that the areas under the ROC curves for NLR and PLR were 0.703 (95% CI: 0.64-0.76) and 0.535 (95% CI: 0.46-06) respectively. Conclusion: NLR can be used as a prognostic marker for COVID-19 given the significant difference of NLR between those died and recovered from COVID-19.
Fecha
2020
Materia
covid-19, prognosis, Neutrophil-to-lymphocyte ratio, Platelet-to-lymphocyte ratio
Fuente
Caspian Journal of Internal Medicine
Editor
Babol University of Medical Sciences
Cobertura
Internal medicine
Colección
Citación
Mohammad Eslamijouybari, Keyvan Heydari, Iradj Maleki, Mahmood Moosazadeh, Akbar Hedayatizadeh-Omran, Lale Vahedi, Roya Ghasemian, Ali Sharifpour, Reza Alizadeh-Navaei, “Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19 Patients and Control Group and Relationship with Disease Prognosis,” SOCICT Open, consulta 17 de abril de 2026, https://www.socictopen.socict.org/items/show/5873.
Position: 16982 (18 views)